PRPH

Q: What is the price of ProPhase Labs (PRPH) today?

The price of ProPhase Labs (PRPH) today is $ 0.11, with return of -82.37% compared to the last year. The price of ProPhase Labs (PRPH) started the year trading around $ 0.76 and today it is at $ 0.11. Follow the real-time price chart, the historical price of ProPhase Labs (PRPH) and international markets.

Q: When does ProPhase Labs (PRPH) pay dividends?

ProPhase Labs (PRPH) did not distribute dividends in the last year.

Q: Is ProPhase Labs (PRPH) worth it?

Currently, ProPhase Labs (PRPH) is priced at $ 0.11, with a P/E of -0.12%, representing a deviation of 413% from its historical average P/E. In the last year, the stock showed a variation of -82.37 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -82.37%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy ProPhase Labs (PRPH) stock?

Investing in stocks of ProPhase Labs (PRPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of ProPhase Labs (PRPH) yield today?

The yield of ProPhase Labs (PRPH) was -59.00% in the last month, -82.37% in the last year and -98.78% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of ProPhase Labs (PRPH) today, the total investment would be $ 11.48, based on the current price of $ 0.11.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2.02In 5 years: $ 0.14In 10 years: $ 2.17It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ProPhase Labs Inc.

Price

$ 0.11

return (12m)

-82.37%

p/e

-0.12

p/bv

0.70

DIVIDEND YIELD

0.00%

price PRPH

PRPH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of PRPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-59.00%

3 months

-73.30%

1 year

-82.37%

2 years

-97.45%

5 years

-98.78%

10 years

-81.06%

Fundamentals PRPH

review the fundamentals of ProPhase Labs shares

P/E

-0.12

Sector: -3.65 Industry: -3.65

P/SALES RATIO (PSR)

4.46

Sector: -3.79 Industry: -3.79

P/BV

0.70

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-63.47%

Sector: -63.54% Industry: -63.54%

ROE

-607.87%

Sector: -66.83% Industry: -66.83%

ROIC

-38.25%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

-100.00%

Sector: -41.11% Industry: -41.11%

GROSS MARGIN

100.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

-100.00%

Sector: -40.98% Industry: -40.98%

P/EBITDA

-0.20

Sector: -3.65 Industry: -3.65

P/EBIT

-0.17

Sector: -3.78 Industry: -3.78

P/ASSET

0.07

Sector: 1.49 Industry: 1.49

BVPS

0.16

Sector: 1.75 Industry: 1.75

EPS

-0.99

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.10

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

-40.53%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

241.33%

Sector: - Industry: -

Fundamentals PRPH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.47	8.35	57.70%	3.36%	$ 223.00 B	32.78%
MRK	13.16	0.00	0.00%	3.23%	$ 250.55 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.67	5.74	32.47%	4.73%	$ 106.71 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.57 B	28.21%
HALO	12.22	14.44	118.17%	0.00%	$ 7.28 B	47.91%
REGN	16.84	2.49	14.79%	0.47%	$ 77.09 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.49	6.68	21.22%	0.00%	$ 115.72 B	31.35%
MCK	25.02	-174.59	-697.75%	0.36%	$ 100.91 B	1.04%
CAH	29.57	-17.27	-58.40%	1.03%	$ 47.17 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.65	2.81	22.24%	0.00%	$ 2.35 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

PRPH Historical Dividends

current DY: 0.00%

5-year average DY: 2.15%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	05/25/2022	06/03/2022	0,30000000
Dividend	03/01/2022	03/10/2022	0,30000000
Dividend	05/25/2021	06/03/2021	0,30000000
Dividend	12/03/2019	12/12/2019	0,25000000
Dividend	01/10/2019	01/24/2019	0,25000000
Dividend	05/21/2018	06/05/2018	0,92630000
Dividend	05/21/2018	06/05/2018	1,00000000

ABOUT THE COMPANY ProPhase Labs

ProPhase Labs Inc.

Average user rating I10

4.0 (0 people)

United States

36 years

Founded: 1989

1995

Time since IPO - 30 years

95

Employees

The Company ProPhase Labs Inc. (United States), is listed on Nasdaq with a market value of $ 4.82 Millions, having an equity of $ 6.86 Millions.

With a total of 95 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 1.08 Million, which generated a loss in the amount of $ -41.70 Millions.

As for its main indicators, the Company has a P/E ratio of -0.12, a P/BV ratio of 0.70 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker PRPH.

Market cap

$ 4.82 Millions

Net worth

$ 6.86 Millions

US$ 6,860,000.00

Assets

$ 65.70 Millions

US$ 65,700,000.00

Total Shares Outstanding

42.00 Millions

42,000,000

Average Daily Trading Volume

$ 2.28 Millions

US$ 2,284,656.24

Sector

Health Care

Industry

Biotechnology

PRPH

PRPH revenue and profits

Financial Results PRPH

DRAG THE FRAME TO SEE MORE DATA

PRPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

25.02

0.36%

ROE

-697.75%

P/BV

-174.59

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.57

1.03%

ROE

-58.40%

P/BV

-17.27

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.16

3.23%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

25.02

0.36%

ROE

-697.75%

P/VP

-174.59

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.57

1.03%

ROE

-58.40%

P/VP

-17.27

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.16

3.23%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of ProPhase Labs (PRPH) today?

The price of ProPhase Labs (PRPH) today is $ 0.11, with return of -82.37% compared to the last year. The price of ProPhase Labs (PRPH) started the year trading around $ 0.76 and today it is at $ 0.11. Follow the real-time price chart, the historical price of ProPhase Labs (PRPH) and international markets.

When does ProPhase Labs (PRPH) pay dividends?

ProPhase Labs (PRPH) did not distribute dividends in the last year.

Is ProPhase Labs (PRPH) worth it?

Currently, ProPhase Labs (PRPH) is priced at $ 0.11, with a P/E of -0.12%, representing a deviation of 413% from its historical average P/E. In the last year, the stock showed a variation of -82.37 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -82.37%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy ProPhase Labs (PRPH) stock?

Investing in stocks of ProPhase Labs (PRPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of ProPhase Labs (PRPH) yield today?

The yield of ProPhase Labs (PRPH) was -59.00% in the last month, -82.37% in the last year and -98.78% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of ProPhase Labs (PRPH) today, the total investment would be $ 11.48, based on the current price of $ 0.11.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2.02
In 5 years: $ 0.14
In 10 years: $ 2.17

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

PRPH

ProPhase Labs Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of PRPH

review the fundamentals of ProPhase Labs shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 2.15%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY ProPhase Labs

ProPhase Labs Inc.

United States

36 years

1995

95

PROFIT X PRICE PRPH

Financial Results PRPH

PRPH cash flow

asset growth - PRPH

PRPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions